Spain heralds ‘Seal’ success
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Spanish self-care association, ANEFP, is celebrating the success of its ‘Seal’ of approval, which it grants, in collaboration with the Spanish Ministry of Health, in recognition of responsible advertisements of OTC medicines. The association has granted 3,934 Seals since the mark came into effect five years ago, with 528 having been issued already in 2018.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.